Ajax-Loading

Hansoh Pharmaceutical Group Co Ltd - Operating Income

Hansoh Pharmaceutical Group Co Ltd's Fiscal Year is From January To December - All Figures are in HKD, Billions.

The item "Operating-Income" stands at 4.38 Billion Hong Kong Dollars for the trailing twelve months (TTM) period ending 06/30/2025, the highest value at least since 03/31/2017, the period currently displayed.'
Regarding the One-Year-Change of the series, the current value constitutes an increase of 10.73 percent compared to the value the year prior.
The 1 year change in percent is 10.73.
The 3 year change in percent is 61.41.
The 5 year change in percent is 81.62.

The Serie's long term average value is 2.73 Billion Hong Kong Dollars. It's latest available value, on 06/30/2025, is 60.27 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 12/31/2016, to it's latest available value, on 06/30/2025, is +139.05%.
The Serie's change in percent from it's maximum value, on 06/30/2025, to it's latest available value, on 06/30/2025, is 0.0%.

Operating Income for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Operating Income905,699,262,464.00
LogoJohnson & Johnson - Operating Income486,508,953,600.00
LogoAbbVie Inc - Operating Income399,570,305,024.00
LogoRoche Holding AG - Operating Income317,433,206,677.55
LogoAstraZeneca PLC - Operating Income280,205,508,085.11